1. Albrand G, Munoz F, Sornay-Rendu E, DuBoeuf F, Delmas PD. 2003; Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. Bone. 32:78–85. DOI:
10.1016/S8756-3282(02)00919-5. PMID:
12584039.
Article
3. Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, Le Couteur DG, Creasey H, Waite LM, Seibel MJ, Sambrook PN. 2010; Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc. 58:2055–2062. DOI:
10.1111/j.1532-5415.2010.03145.x. PMID:
21054284.
Article
4. van den Berg LE, Zandbergen AA, van Capelle CI, de Vries JM, Hop WC, van den Hout JM, Reuser AJ, Zillikens MC, van der Ploeg AT. 2010; Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density. Bone. 47:643–649. DOI:
10.1016/j.bone.2010.06.021. PMID:
20601298.
6. Kanis J. On behalf of the World Health Organization Scientific Group. 2018. Assessment of osteoporosis at the primary health-care level. Technical report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield;Sheffield: DOI:
10.1007/s00198-017-4151-8.
7. Janssen I, Heymsfield SB, Ross R. 2002; Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 50:889–896. DOI:
10.1046/j.1532-5415.2002.50216.x. PMID:
12028177.
Article
8. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. 2009; Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 8:18–30. DOI:
10.1016/j.arr.2008.07.002. PMID:
18692159. PMCID:
PMC3782993.
Article
11. Kawao N, Kaji H. 2015; Interactions between muscle tissues and bone metabolism. J Cell Biochem. 116:687–695. DOI:
10.1002/jcb.25040. PMID:
25521430.
Article
12. Beck BR, Daly RM, Singh MA, Taaffe DR. 2017; Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis. J Sci Med Sport. 20:438–445. DOI:
10.1016/j.jsams.2016.10.001. PMID:
27840033.
Article
13. Greig CA, Gray C, Rankin D, Young A, Mann V, Noble B, Atherton PJ. 2011; Blunting of adaptive responses to resistance exercise training in women over 75y. Exp Gerontol. 46:884–890. DOI:
10.1016/j.exger.2011.07.010. PMID:
21821111.
Article
14. Karinkanta S, Heinonen A, Sievänen H, Uusi-Rasi K, Pasanen M, Ojala K, Fogelholm M, Kannus P. 2007; A multi-component exercise regimen to prevent functional decline and bone fragility in home-dwelling elderly women: randomized, controlled trial. Osteoporos Int. 18:453–462. DOI:
10.1007/s00198-006-0256-1. PMID:
17103296.
Article
15. Javaheri B, Pitsillides AA. 2019; Aging and mechanoadaptive responsiveness of bone. Curr Osteoporos Rep. 17:560–569. Erratum in:
Curr Osteoporos Rep. 2020. doi: 10.1007/s11914-019-00553-7. DOI:
10.1007/s11914-019-00553-7. PMID:
31760583. PMCID:
PMC6944648.
Article
16. Spencer EM, Liu CC, Si EC, Howard GA. 1991; In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone. 12:21–26. DOI:
10.1016/8756-3282(91)90050-S. PMID:
2054232.
Article
19. Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G. 2016; Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. 23:1078–1092. Erratum in:
Cell Metab. 2017;25:218. DOI:
10.1016/j.cmet.2016.05.004. PMID:
27304508. PMCID:
PMC4910629.
Article
20. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT. 2003; Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem. 278:32005–32013. Erratum in:
J Biol Chem. 2003;278:45040. DOI:
10.1016/S0021-9258(20)82534-4. PMID:
12788918.
Article
21. Ou G, Charles L, Matton S, Rodner C, Hurley M, Kuhn L, Gronowicz G. 2010; Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone. J Gerontol A Biol Sci Med Sci. 65:1051–1059. DOI:
10.1093/gerona/glq114. PMID:
20643704. PMCID:
PMC2949335.
Article
22. Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, Oki J, Imamura T. 2005; Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol. 186:273–289. DOI:
10.1677/joe.1.06055. PMID:
16079254.
Article
23. Shetty AK, Hattiangady B, Shetty GA. 2005; Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia. 51:173–186. DOI:
10.1002/glia.20187. PMID:
15800930.
Article
24. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. 2004; Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 113:561–568. DOI:
10.1172/JCI200419081. PMCID:
PMC338262. PMID:
14966565.
Article
25. Zhang Y, Xie Y, Berglund ED, Coate KC, He TT, Katafuchi T, Xiao G, Potthoff MJ, Wei W, Wan Y, Yu RT, Evans RM, Kliewer SA, Mangelsdorf DJ. 2012; The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife. 1:e00065. DOI:
10.7554/eLife.00065. PMID:
23066506. PMCID:
PMC3466591. PMID:
4b4ce4845cdd40c5b506669b2962b9ef.
Article
26. Wöhrle S, Henninger C, Bonny O, Thuery A, Beluch N, Hynes NE, Guagnano V, Sellers WR, Hofmann F, Kneissel M, Graus Porta D. 2013; Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets. J Bone Miner Res. 28:899–911. DOI:
10.1002/jbmr.1810. PMID:
23129509.
Article
27. Duncan ND, Williams DA, Lynch GS. 1998; Adaptations in rat skeletal muscle following long-term resistance exercise training. Eur J Appl Physiol Occup Physiol. 77:372–378. DOI:
10.1007/s004210050347. PMID:
9562367.
Article
28. Meyer OA, Tilson HA, Byrd WC, Riley MT. 1979; A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1:233–236. PMID:
551317.
29. Halldorsdottir S, Carmody J, Boozer CN, Leduc CA, Leibel RL. 2009; Reproducibility and accuracy of body composition assessments in mice by dual energy x-ray absorptiometry and time domain nuclear magnetic resonance. Int J Body Compos Res. 7:147–154. PMID:
21909234. PMCID:
PMC3169293.
30. Bevier WC, Wiswell RA, Pyka G, Kozak KC, Newhall KM, Marcus R. 1989; Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J Bone Miner Res. 4:421–432. DOI:
10.1002/jbmr.5650040318. PMID:
2763878.
Article
31. Li X, Mohan S, Gu W, Wergedal J, Baylink DJ. 2001; Quantitative assessment of forearm muscle size, forelimb grip strength, forearm bone mineral density, and forearm bone size in determining humerus breaking strength in 10 inbred strains of mice. Calcif Tissue Int. 68:365–369. DOI:
10.1007/s00223-001-0004-7. PMID:
11685425.
Article
32. Baek K, Hwang HR, Park HJ, Kwon A, Qadir AS, Ko SH, Woo KM, Ryoo HM, Kim GS, Baek JH. 2014; TNF-α upregulates sclerostin expression in obese mice fed a high-fat diet. J Cell Physiol. 229:640–650. DOI:
10.1002/jcp.24487. PMID:
24446199.
Article
33. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. 2001; Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 98:14440–14445. DOI:
10.1073/pnas.251541198. PMID:
11717410. PMCID:
PMC64700.
Article
34. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. 2004; Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:399–412. DOI:
10.1016/S0092-8674(04)00400-3. PMID:
15109499. PMCID:
PMC3619734.
Article
35. Clavel S, Coldefy AS, Kurkdjian E, Salles J, Margaritis I, Derijard B. 2006; Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle. Mech Ageing Dev. 127:794–801. DOI:
10.1016/j.mad.2006.07.005. PMID:
16949134.
Article
36. Kirby TJ, Lee JD, England JH, Chaillou T, Esser KA, McCarthy JJ. 2015; Blunted hypertrophic response in aged skeletal muscle is associated with decreased ribosome biogenesis. J Appl Physiol (1985). 119:321–327. DOI:
10.1152/japplphysiol.00296.2015. PMID:
26048973. PMCID:
PMC4538281.
Article
37. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM. 2006; Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol (1985). 101:531–544. DOI:
10.1152/japplphysiol.01474.2005. PMID:
16614355.
Article
38. Slivka D, Raue U, Hollon C, Minchev K, Trappe S. 2008; Single muscle fiber adaptations to resistance training in old (>80 yr) men: evidence for limited skeletal muscle plasticity. Am J Physiol Regul Integr Comp Physiol. 295:R273–R280. DOI:
10.1152/ajpregu.00093.2008. PMID:
18448613. PMCID:
PMC2494807.
Article
40. Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F. 2008; Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 32:959–966. DOI:
10.1038/ijo.2008.11. PMID:
18283284. PMCID:
PMC2877506.
Article
42. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003; Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development. 130:3063–3074. DOI:
10.1242/dev.00491. PMID:
12756187.
Article
43. White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, Fitzpatrick D, Yu K, Ornitz DM, Econs MJ. 2005; Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet. 76:361–367. DOI:
10.1086/427956. PMID:
15625620. PMCID:
PMC1196382.
Article
44. Dono R, Texido G, Dussel R, Ehmke H, Zeller R. 1998; Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17:4213–4225. DOI:
10.1093/emboj/17.15.4213. PMID:
9687490. PMCID:
PMC1170755.
Article
45. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. 2008; Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev. 17:725–736. DOI:
10.1089/scd.2007.0230. PMID:
18788932.
Article
46. Patel VS, Judex S, Rubin J, Rubin CT. Bilezikian JP, Martin TJ, Clemens TL, Rosen CJ, editors. 2020. Mechanisms of exercise effects on bone quantity and quality. Principles of bone biology. 4th ed. Academic Press;Cambridge: p. 1759–1784. DOI:
10.1016/B978-0-12-814841-9.00076-2.
Article
50. Kirk B, Feehan J, Lombardi G, Duque G. 2020; Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep. 18:388–400. DOI:
10.1007/s11914-020-00599-y. PMID:
32529456.
Article
52. Steringer JP, Müller HM, Nickel W. 2015; Unconventional secretion of fibroblast growth factor 2--a novel type of protein translocation across membranes? J Mol Biol. 427(6 Pt A):1202–1210. DOI:
10.1016/j.jmb.2014.07.012. PMID:
25051502.
Article
53. Fujimura R, Ashizawa N, Watanabe M, Mukai N, Amagai H, Fukubayashi T, Hayashi K, Tokuyama K, Suzuki M. 1997; Effect of resistance exercise training on bone formation and resorption in young male subjects assessed by biomarkers of bone metabolism. J Bone Miner Res. 12:656–662. DOI:
10.1359/jbmr.1997.12.4.656. PMID:
9101378.
Article